Targeted therapies aimed at multiple specific cell types within a tumor represent a precision approach to cancer treatment. By identifying and attacking distinct populations—such as cancer stem cells, rapidly dividing tumor cells, and supportive stromal or immune cells—these treatments work to disrupt tumor growth on several fronts. This multi-pronged strategy can reduce resistance, improve treatment effectiveness, and limit damage to healthy tissue. Techniques include combination drug therapies, engineered immune cells, and nanoparticles designed to deliver therapies selectively. By addressing the tumor’s complexity at the cellular level, these approaches offer a more tailored, potent, and sophisticated path toward improved patient outcomes.
Home